Prevalence of Pulmonary Hypertension and its Influence on Survival in Patients With Advanced Chronic Obstructive Pulmonary Disease Prior to Lung Transplantation

References

• Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet 2012; 379(9823):1341–1351.
   Google Scholar
• Battaglia S, Basile M, Scichilone N, Bellia V. Prevalence of co-morbidities and severity of COPD. COPD 2014 Nov 21. [ Epub ahead of print]
   Google Scholar
• Hersh CP, Make BJ, Lynch DA, Barr RG, Bowler RP, Calverley PM, Castaldi PJ, Cho MH, Coxson HO, DeMeo DL, Foreman MG, Han MK, Harshfield BJ, Hokanson JE, Lutz S, Ramsdell JW, Regan EA, Rennard SI, Schroeder JD, Sciurba FC, Steiner RM, Tal-Singer R, van Beek E Jr, Silverman EK, Crapo JD; COPDGene, ECLIPSE Investigators. Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus. BMC Pulm Med 2014; 14:164.
   Google Scholar
• Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S. Epidemiology of atrial fibrillation: European perspective. Clin Epidemiol 2014; 6:213–220.
   PubMed Web of Science ®Google Scholar
• Seeger W, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V, De Marco T, Galiè N, Ghio S, Gibbs S, Martinez FJ, Semigran MJ, Simonneau G, Wells AU, Vachiéry JL. Pulmonary hypertension in chronic lung diseases. J Am Coll Cardiol 2013; 62(25 Suppl):D109–116.
   PubMed Web of Science ®Google Scholar
• Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Krishna Kumar R, Landzberg M, Machado RF, Olschewski H, Robbins IM, Souza R. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013; 62(25 Suppl):D34–41.
   PubMed Web of Science ®Google Scholar
• Yusen RD, Edwards LB, Kucheryavaya AY, Benden C, ­Dipchand AI, Dobbels F, Goldfarb SB, Levvey BJ, Lund LH, Meiser B, Stehlik J; International Society for Heart and Lung Transplantation. The registry of the International Society for Heart and Lung Transplantation: 35 adult lung and heart-lung transplant report–2014; focus theme: retransplantation. J Heart Lung Transpl 2014; 33(10):1009–24.
   PubMed Web of Science ®Google Scholar
• O'Keefe KL, Kilic A, Pope-Harman A, Hayes D Jr, Kirkby S, Higgins RS, Whitson BA. Changes in pulmonary artery pressure affect survival differently in lung transplant recipients who have pulmonary hypertension or chronic obstructive pulmonary disease. Exp Clin Transpl 2014; 12(4):283–289.
   PubMed Web of Science ®Google Scholar
• United Network for Organ Sharing / Organ Procurement and Transplantation Network Standard Transplant Analysis and Research Database. Available from: http://optn.transplant.hrsa.gov/data/about/OPTNDatabase.asp ( accessed 6 September 2013).
   Google Scholar
• Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Primary pulmonary hypertension. A national prospective study. Ann Intern Med 1987; 107(2):216–223.
   PubMed Web of Science ®Google Scholar
• Simonneau G, Galiè N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, Gibbs S, Lebrec D, Speich R, Beghetti M, Rich S, Fishman A. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43(12 Suppl S):5S–12S.
   PubMed Web of Science ®Google Scholar
• Carlsen J, Hasseriis Andersen K, Boesgaard S, Iversen M, Steinbrüchel D, Bøgelund Andersen C. Pulmonary arterial lesions in explanted lungs after transplantation correlate with severity of pulmonary hypertension in chronic obstructive pulmonary disease. J Heart Lung Transpl 2013; 32(3):347–354.
   PubMed Web of Science ®Google Scholar
• Cuttica MJ, Kalhan R, Shlobin OA, Ahmad S, Gladwin M, Machado RF, Barnett SD, Nathan SD. Categorization and impact of pulmonary hypertension in patients with advanced COPD. Respir Med 2010; 104(12):1877–1882.
   PubMed Web of Science ®Google Scholar
• Thabut G, Dauriat G, Stern JB, Logeart D, Lévy A, Marrash-Chahla R, Mal H. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest 2005; 127(5):1531–1536.
   PubMed Web of Science ®Google Scholar
• Minai OA, Chaouat A, Adnot S. Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective. Chest 2010; 137(6 Suppl):39S–51S.
   PubMed Web of Science ®Google Scholar
• Minai OA, Fessler H, Stoller JK, Criner GJ, Scharf SM, Meli Y, Nutter B, DeCamp MM; NETT Research Group. Clinical characteristics and prediction of pulmonary hypertension in severe emphysema. Respir Med 2014; 108(3):482–490.
   PubMed Web of Science ®Google Scholar
• Gologanu D, Stanescu C, Ursica T, Balea MI, Ionita D, Bogdan MA. Prevalence and characteristics of pulmonary hypertension associated with COPD - A pilot study in patients referred to a pulmonary rehabilitation program clinic. Maedica (Buchar) 2013; 8(3):243–248.
   PubMedGoogle Scholar
• Brecker SJ, Gibbs JS, Fox KM, Yacoub MH, Gibson DG. Comparison of Doppler derived haemodynamic variables and simultaneous high fidelity pressure measurements in severe pulmonary hypertension. Br Heart J 1994; 72(4):384–389.
   PubMedGoogle Scholar
• Arcasoy SM, Christie JD, Ferrari VA, Sutton MS, Zisman DA, Blumenthal NP, Pochettino A, Kotloff RM. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003; 167(5):735–740.
   PubMed Web of Science ®Google Scholar
• Kessler R, Faller M, Weitzenblum E, Chaouat A, Aykut A, Ducoloné A, Ehrhart M, Oswald-Mammosser M. “Natural history” of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease. Am J Respir Crit Care Med 2001; 164(2):219–224.
   PubMed Web of Science ®Google Scholar
• Hurdman J, Condliffe R, Elliot CA, Swift A, Rajaram S, Davies C, Hill C, Hamilton N, Armstrong IJ, Billings C, Pollard L, Wild JM, Lawrie A, Lawson R, Sabroe I, Kiely DG. Pulmonary hypertension in COPD: results from the ASPIRE registry. Eur Respir J 2013; 41(6):1292–1301.
   PubMed Web of Science ®Google Scholar
• Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J 2008; 32(5):1371–1385.
   PubMed Web of Science ®Google Scholar
• Sims MW, Margolis DJ, Localio AR, Panettieri RA, Kawut SM, Christie JD. Impact of pulmonary artery pressure on exercise function in severe COPD. Chest 2009; 136(2):412–419.
   PubMed Web of Science ®Google Scholar
• Wrobel JP, Thompson BR, Williams TJ. Mechanisms of pulmonary hypertension in chronic obstructive pulmonary disease: a pathophysiologic review. J Heart Lung Transpl 2012; 31(6):557–564.
   PubMed Web of Science ®Google Scholar
• Baughman P, Marott JL, Lange P, Martin CJ, Shankar A, Petsonk EL, Hnizdo E. Combined effect of lung function level and decline increases morbidity and mortality risks. Eur J Epidemiol 2012; 27(12):933–943.
   PubMed Web of Science ®Google Scholar
• Boutou AK, Nair A, Douraghi-Zadeh D, Sandhu R, Hansell DM, Wells AU, Polkey MI, Hopkinson NS. A combined pulmonary function and emphysema score prognostic index for staging in chronic obstructive pulmonary disease. PLoS One 2014; 9(10):e111109.
   PubMed Web of Science ®Google Scholar
• Spruit MA, Polkey MI, Celli B, Edwards LD, Watkins ML, Pinto-Plata V, Vestbo J, Calverley PM, Tal-Singer R, Agusti A, Coxson HO, Lomas DA, MacNee W, Rennard S, Silverman EK, Crim CC, Yates J, Wouters EF; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) study investigators. Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease. J Am Med Dir Assoc 2012; 13(3):291–297.
   PubMed Web of Science ®Google Scholar
• Polkey MI, Spruit MA, Edwards LD, Watkins ML, Pinto-Plata V, Vestbo J, Calverley PM, Tal-Singer R, Agustí A, Bakke PS, Coxson HO, Lomas DA, MacNee W, Rennard S, Silverman EK, Miller BE, Crim C, Yates J, Wouters EF, Celli B; Evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE) Study Investigators. Six-minute-walk test in chronic obstructive pulmonary disease: minimal clinically important difference for death or hospitalization. Am J Respir Crit Care Med 2013; 187(4):382–386.
   PubMed Web of Science ®Google Scholar
• Golpe R, Pérez-de-Llano LA, Méndez-Marote L, Veres-Racamonde A. Prognostic value of walk distance, work, oxygen saturation, and dyspnea during 6-minute walk test in COPD patients. Respir Care 2013; 58(8):1329–1334.
   PubMed Web of Science ®Google Scholar
• de Torres JP, Casanova C, Cote CG, López MV, Díaz O, María Marin J, Pinto-Plata V, Montes de Oca M, Aguirre-Jaime A, Celli BR. Six-minute walking distance in women with COPD. COPD 2011; 8(4):300–305.
   PubMedGoogle Scholar
• Gudmundsson G, Gislason T, Lindberg E, Hallin R, Ulrik CS, Brøndum E, Nieminen MM, Aine T, Bakke P, Janson C. Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidity. Respir Res 2006; 7:109.
   PubMed Web of Science ®Google Scholar
• Hasegawa W, Yamauchi Y, Yasunaga H, Sunohara M, Jo T, ­Matsui H, Fushimi K, Takami K, Nagase T. Factors affecting mortality following emergency admission for chronic obstructive pulmonary disease. BMC Pulm Med 2014; 14:151.
   PubMed Web of Science ®Google Scholar
• Piquet J, Chavaillon JM, David P, Martin F, Blanchon F, Roche N; French College of General Hospital Respiratory Physicians (CPHG). High-risk patients following hospitalisation for an acute exacerbation of COPD. Eur Respir J 2013; 42(4):946–955.
   PubMed Web of Science ®Google Scholar
• Stolz D, Meyer A, Rakic J, Boeck L, Scherr A, Tamm M. Mortality risk prediction in COPD by a prognostic biomarker panel. Eur Respir J 2014; 44(6):1557–1570.
   PubMed Web of Science ®Google Scholar
• Ongel EA, Karakurt Z, Salturk C, Takir HB, Burunsuzoglu B, Kargin F, Ekinci GH, Mocin O, Gungor G, Adiguzel N, Yilmaz A. How do COPD comorbidities affect ICU outcomes? Int J Chron Obstruct Pulmon Dis 2014; 9:1187–1196.
   PubMed Web of Science ®Google Scholar